Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
39,518,605
-
Total 13F shares
-
10,483,926
-
Share change
-
+170,125
-
Total reported value
-
$12,366,901
-
Price per share
-
$1.18
-
Number of holders
-
35
-
Value change
-
-$11,282,467
-
Number of buys
-
15
-
Number of sells
-
25
Institutional Holders of Keenova Therapeutics plc - Common Stock, par value $0.01 per share (MNKTQ) as of Q2 2023
As of 30 Jun 2023,
Keenova Therapeutics plc - Common Stock, par value $0.01 per share (MNKTQ) was held by
35 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,483,926 shares.
The largest 10 holders included
Bracebridge Capital, LLC, Alta Fundamental Advisers LLC, JPMORGAN CHASE & CO, Hudson Bay Capital Management LP, CONTINENTAL GENERAL INSURANCE CO, Sculptor Capital LP, VANGUARD GROUP INC, Two Seas Capital LP, BlackRock Inc., and BANK OF AMERICA CORP /DE/.
This page lists
35
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.